600594 Stock Overview
Researches, develops, produces, and sells pharmaceutical products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 5/6 |
| Dividends | 3/6 |
Guizhou Yibai Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥3.82 |
| 52 Week High | CN¥6.14 |
| 52 Week Low | CN¥2.76 |
| Beta | 0.41 |
| 11 Month Change | 4.09% |
| 3 Month Change | 29.93% |
| 1 Year Change | -37.17% |
| 33 Year Change | -38.78% |
| 5 Year Change | -18.72% |
| Change since IPO | -77.87% |
Recent News & Updates
Recent updates
Shareholder Returns
| 600594 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.3% | -1.5% | -2.1% |
| 1Y | -37.2% | -9.4% | 2.8% |
Return vs Industry: 600594 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 600594 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 600594 volatility | |
|---|---|
| 600594 Average Weekly Movement | 5.7% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 600594 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 600594's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 5,509 | Ya Qi Dou | www.gzcci.com |
Guizhou Yibai Pharmaceutical Co., Ltd. researches, develops, produces, and sells pharmaceutical products in China. It offers products in the form of capsules, tablets, granules, syrups, small-volume injections, freeze-dried powder injections, pills, and oral solutions in the areas of tumor system, cerebrovascular, respiratory system, rheumatism, digestive system, pediatric, gynecological, anti-infection, anti-inflammatory, analgesic, and other diseases. The company was founded in 1995 and is based in Guiyang, China.
Guizhou Yibai Pharmaceutical Co., Ltd. Fundamentals Summary
| 600594 fundamental statistics | |
|---|---|
| Market cap | CN¥3.01b |
| Earnings (TTM) | -CN¥235.62m |
| Revenue (TTM) | CN¥2.40b |
1.3x
P/S Ratio-12.8x
P/E RatioIs 600594 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 600594 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.40b |
| Cost of Revenue | CN¥955.85m |
| Gross Profit | CN¥1.44b |
| Other Expenses | CN¥1.68b |
| Earnings | -CN¥235.62m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Nov 28, 2024
| Earnings per share (EPS) | -0.30 |
| Gross Margin | 60.13% |
| Net Profit Margin | -9.83% |
| Debt/Equity Ratio | 30.3% |
How did 600594 perform over the long term?
See historical performance and comparison